Recent Patent Cases and Generic Delays: 2023-2025 Examples
Dec, 21 2025
Medications
Bob Bond
Despite FDA approval, many generic drugs face multi-year delays due to patent litigation. From 2023 to 2025, patients paid thousands more for brand-name drugs because generics were blocked by legal tactics-not safety issues.
